STUDIES ON GUINEA-PIG MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) .2. PURIFICATION OF MIF AFTER TREATMENT WITH REDUCING AND DENATURING AGENTS

被引：0

作者：

KOTKES, P ^{[1
]}

PICK, E ^{[1
]}

机构：

[1] TEL AVIV UNIV, SACKLER SCH MED, DEPT HUMAN MICROBIOL, IMMUNOL SECT, RAMAT AVIV, ISRAEL

来源：

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1979年 / 37卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：540 / 550

页数：11

共 50 条

[31] INTERACTION OF LOTUS-TETRAGONOLOBUS LECTIN (LTL) AND AN MIF-LIKE FACTOR WITH GUINEA-PIG MACROPHAGES .1. EFFECTS ON MACROPHAGE-MIGRATION INHIBITION AND RECEPTOR-BINDING STUDIES
FAHLBUSCH, B
WOLLWEBER, L
DROSSLER, K
SCHERBAUM, I
ZSCHIESCHE, W
IMMUNOBIOLOGY, 1982, 162 (03) : 251 - 264
[32] PURIFICATION OF ANTIGEN-DEPENDENT MACROPHAGE-MIGRATION INHIBITION FACTOR (MIF) FROM LYMPH DRAINING A TUBERCULIN REACTION
SCOTT, DM
MCCONNELL, I
AGOMO, P
LACHMANN, PJ
IMMUNOLOGY, 1978, 34 (04) : 591 - 604
[33] Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): Use of biologically active labeled MIF derivatives
Kleemann, R
Grell, M
Mishcke, R
Zimmermann, G
Bernhagen, J
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (03) : 351 - 363
[34] The Role of Macrophage Migration Inhibitory Factor (MIF) as a Novel Therapeutic Target for Diabetes Treatment
Sanchez-Zamora, Yuriko
Terrazas, Luis I.
Leal, Emmanuel
Juarez, Imelda
Selecki, Thais
Satoskar, Abhay R.
Rodriguez-Sosa, Miriam
Vilches-Flores, Alonso
DIABETES, 2010, 59 : A363 - A364
[35] CELLULAR SOURCE AND CHEMICAL CHARACTERIZATION OF IMMUNE INTERFERON (TYPE-II) AND MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) OF MOUSE
NEUMANN, C
PALM, I
KUHNER, A
SORG, C
ZEITSCHRIFT FUR IMMUNITATSFORSCHUNG-IMMUNOBIOLOGY, 1977, 153 (04): : 337 - 338
[36] MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) MEDIATES TET2 CHIP ATHEROSCLEROSIS
Heimlich, Brett
Parker, Alyssa
Vlasschaert, Caitlyn
Ferrell, Paul
Bick, Alexander
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 4601 - 4601
[37] LOCALIZATION OF MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) TO SECRETORY GRANULES WITHIN THE CORTICOTROPIC AND THYROTROPIC CELLS OF THE PITUITARY-GLAND
NISHINO, T
BERNHAGEN, J
SHIIKI, H
CALANDRA, T
DOHI, K
BUCALA, R
MOLECULAR MEDICINE, 1995, 1 (07) : 781 - 788
[38] TRYPSIN TREATMENT DIFFERENTIATE MACROPHAGE ACTIVATING FACTOR (MAF) FROM MIGRATION-INHIBITORY FACTOR (MIF)
CHURCHILL, WH
MEDNIS, AD
REMOLD, HG
FEDERATION PROCEEDINGS, 1980, 39 (03) : 1156 - 1156
[39] CHARACTERIZATION OF MACROPHAGE-MIGRATION INHIBITORY FACTOR ACTIVITY PRODUCED INVIVO BY A CELL-MEDIATED IMMUNE-REACTION IN GUINEA-PIG
POSTLETHWAITE, AE
TOWNES, AS
KANG, AH
JOURNAL OF IMMUNOLOGY, 1976, 117 (05) : 1716 - 1720
[40] HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) IS PRODUCED BY T-CELLS AND T-CELLS BUT NOT BY B-CELLS
WEISER, W
ZACKS, S
REMOLD, H
DAVID, J
FEDERATION PROCEEDINGS, 1986, 45 (03) : 627 - 627

← 1 2 3 4 5 →